Literature DB >> 33837918

Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study.

Serena M Passamonti1, Andrea Artoni2, Giorgio Carrabba3, Giuliana Merati4, Maria Abbattista2, Marco Capecchi5, Massimo Castellani6, Cristina Marenghi7, Elena Trombetta8, Lorenzo Giammattei3, Manuela Caroli3, Paolo Bucciarelli2, Erica Scalambrino2, Flora Peyvandi2,4, Ida Martinelli9.   

Abstract

Primary brain tumors are associated with an increased risk of pulmonary embolism (PE), particularly in the early post-operative period. The pathophysiological mechanisms of PE are poorly understood. This study aims to describe prospectively extracellular vesicles (EVs) levels and investigate whether or not their variations allow to identify patients at increased risk of post-operative PE. Consecutive meningioma or glioma patients candidate to tumor resection were included in the study if a pulmonary perfusion scan (Q-scan) performed before surgery ruled out PE. EVs derived from platelets (CD41+) or endothelial cells (CD144+), tissue factor-bearing EVs (CD142+) and their procoagulant subtype (annexin V+) were analyzed by flow cytometry before surgery (T0), within 24 h (T1), two (T2) and seven days (T7) after surgery. Q-scan was repeated at T2. Ninety-three patients with meningioma, 59 with glioma and 76 healthy controls were included in the study. CD142+ and annexin V+/CD142+ EVs were increased at T0 in meningioma and glioma patients compared to healthy controls. Twenty-nine meningioma (32%) and 16 glioma patients (27%) developed PE at T2. EVs levels were similar in meningioma patients with or without PE, whereas annexin V+ and annexin V+/CD142+ EVs were significantly higher at T1 and T2 in glioma patients with PE than in those without. Procoagulant EVs, particularly annexin V+/CD142+, increase after surgery and are more prevalent in glioma patients who developed PE after surgery than in those who did not.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; Glioma; Meningioma; Thrombosis

Mesh:

Substances:

Year:  2021        PMID: 33837918     DOI: 10.1007/s11239-021-02441-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  2 in total

1.  Circulating Small Extracellular Vesicles Profiling and Thrombin Generation as Potential Markers of Thrombotic Risk in Glioma Patients.

Authors:  Olga Melnichnikova; Yulia Zhilenkova; Olga Sirotkina; Ekaterina Zolotova; Konstantin Pishchulov; Malik Tastanbekov; Artem Paltsev; Maria Simakova
Journal:  Front Cardiovasc Med       Date:  2022-06-23

2.  Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.

Authors:  Fleur H J Kaptein; Milou A M Stals; Maaike Y Kapteijn; Suzanne C Cannegieter; Linda Dirven; Sjoerd G van Duinen; Ronald van Eijk; Menno V Huisman; Eva E Klaase; Martin J B Taphoorn; Henri H Versteeg; Jeroen T Buijs; Johan A F Koekkoek; Frederikus A Klok
Journal:  J Thromb Haemost       Date:  2022-05-09       Impact factor: 16.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.